Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1103/PhysRevLett.111.119601 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Letter to the editor for the article "Hyper-realistic rendering-assisted laparoscopic adrenalectomy for giant adrenal tumors: a pilot study".
World J Urol
December 2024
Department of Urology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).
Rev Med Interne
January 2025
Service de Médecine Interne et Immunologie Clinique, CHU de Dijon, Dijon, France.
Article Synopsis
- The purpose of this project was to update the 2016 recommendations regarding the management of immunosuppressants or biologics in patients with giant cell arteritis (GCA).
- A task force of 18 physicians developed 26 validated recommendations after thorough discussion and a >85% consensus process.
- Key recommendations include using subcutaneous tocilizumab (TCZ) as a first-line treatment when glucocorticoid-sparing is needed, initiating TCZ at diagnosis for patients with specific high-risk conditions, and considering TCZ or methotrexate if glucocorticoid discontinuation is not feasible after 12 months.
Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions.
World J Gastrointest Oncol
October 2024
Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Recently, we read the article "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature" published in the . The prognosis of advanced hepatocellular carcinoma (HCC) is poor, and multidisciplinary comprehensive treatment is currently the main research direction. This case report demonstrated the efficacy of the combination therapy of transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, epclusa, lenvatinib and sintilimab for a patient with advanced HCC, and the report can serve as a reference for clinical practice.
View Article and Find Full Text PDFImproving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy.
World J Gastrointest Oncol
October 2024
Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.
In this editorial, I comment on three articles published in the recent issue of the . Hepatocellular carcinoma (HCC) is an important public health concern, and there are three articles on the theme of HCC in this issue. I focus on the articles by Mu , Chu , and Ma for this editorial.
View Article and Find Full Text PDFDeep Learning to Discriminate Arteritic From Nonarteritic Ischemic Optic Neuropathy on Color Images.
JAMA Ophthalmol
November 2024
Department of Neuro-Ophthalmology and Rothschild Neurovisual and Computational Sciences BRAIN Lab, Rothschild Foundation Hospital, Paris, France.
Article Synopsis
- The study focuses on improving the diagnosis of arteritic anterior ischemic optic neuropathy (AAION) from giant cell arteritis, which can prevent vision loss, particularly when symptoms are subtle or unreliable tests are involved.
- Researchers developed a deep learning system (DLS) to differentiate between AAION and nonarteritic anterior ischemic optic neuropathy (NAION) by analyzing color fundus images from a large international dataset involving 961 eyes from 802 patients.
- The DLS demonstrated promising performance metrics, such as area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy, validating its potential as a diagnostic tool during the acute phase.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!